FAMI
AZN icon

Fideuram Asset Management (Ireland)’s AstraZeneca AZN Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
93,902
+84,194
+867% +$15.8M 0.25% 110
2026
Q1 		$1.35M Buy
+9,708
New +$1.87M 0.17% 165

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s AZN Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) increased its AstraZeneca (AZN) stake by 867% in Q2 2026, buying an estimated $15.8M and bringing the position to 93,902 shares worth $13M. The position accounts for 0.25% of the portfolio, ranked #110.

Fideuram Asset Management (Ireland) first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,497 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 93,902 shares of AstraZeneca worth $13M as of Q2 2026.
  • Fideuram Asset Management (Ireland) bought 84,194 AstraZeneca shares in Q2 2026, an estimated $15.8M.
  • AstraZeneca made up 0.25% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #110 holding.
  • Fideuram Asset Management (Ireland) first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,497 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.